Affinity selection-mass spectrometry screening techniques for small molecule drug discovery
The DOI matches its Crossref record.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Identification of bioactive metabolites using activity metabolomics
Rinschen, M. M., Ivanisevic, J., Giera, M., & Siuzdak, G. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0108-4 · Cited by 1,008
An orally available non-nucleotide STING agonist with antitumor activity
Pan, B.-S., Perera, S. A., Piesvaux, J. A., Presland, J. P., Schroeder, G. K., Cumming, J. N., Trotter, B. W., Altman, M. D., Buevich, A. V., Cash, B., et al. (2020) · Science · doi:10.1126/science.aba6098 · Cited by 694
“S7, A to D, and text S2) when assessed with a mass spectrometry–based technique that isolates and identifies protein-bound compounds [automated ligand identification system (ALIS)] (21).”
MethodDrug–protein binding: a critical review of analytical tools
Vuignier, K., Schappler, J., Veuthey, J.-L., Carrupt, P.-A., & Martel, S. (2010) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-010-3737-1 · Cited by 389
High-Throughput Screening: today’s biochemical and cell-based approaches
Blay, V., Tolani, B., Ho, S. P., & Arkin, M. R. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.07.024 · Cited by 387
Biophysics in drug discovery: impact, challenges and opportunities
Renaud, J.-P., Chung, C.-W., Danielson, U. H., Egner, U., Hennig, M., Hubbard, R. E., & Nar, H. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.123 · Cited by 382
WD40 repeat domain proteins: a novel target class?
Schapira, M., Tyers, M., Torrent, M., & Arrowsmith, C. H. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.179 · Cited by 335
Therapeutic strategies targeting FOXO transcription factors
Calissi, G., Lam, E. W.-F., & Link, W. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0088-2 · Cited by 330
Nagashima, T., Shigematsu, N., Maruki, R., Urano, Y., Tanaka, H., Shimaya, A., Shimokawa, T., & Shibasaki, M. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.065714 · Cited by 275
Exploring new targets and chemical space with affinity selection-mass spectrometry
Prudent, R., Annis, D. A., Dandliker, P. J., Ortholand, J.-Y., & Roche, D. (2020) · Nature Reviews Chemistry · doi:10.1038/s41570-020-00229-2 · Cited by 104
Self-citationA small molecule inhibitor of Rheb selectively targets mTORC1 signaling
Mahoney, S. J., Narayan, S., Molz, L., Berstler, L. A., Kang, S. A., Vlasuk, G. P., & Saiah, E. (2018) · Nature Communications · doi:10.1038/s41467-018-03035-z · Cited by 88
Identification of oleoylethanolamide as an endogenous ligand for HIF-3α
Diao, X., Ye, F., Zhang, M., Ren, X., Tian, X., Lu, J., Sun, X., Hou, Z., Chen, X., Li, F., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30338-z · Cited by 51
Mikhailov, V. A., Griffiths, R. L., & Cooper, H. J. (2017) · International Journal of Mass Spectrometry · doi:10.1016/j.ijms.2016.09.011 · Cited by 41
“This approach can be used for high-throughput screening for binding ligands, but the indirect assessment of non-covalent interactions between the protein and the ligands via detection of the ligand molecules by DESI is not entirely conclusive, because the presence of the immobilising agent can produce false positive r…”
BackgroundAdvances in Ultrahigh Throughput Hit Discovery with Tandem Mass Spectrometry Encoded Libraries
Mata, J. M., van der Nol, E., & Pomplun, S. J. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c04899 · Cited by 27
Gabriel, J., Höfner, G., & Wanner, K. T. (2019) · Frontiers in Chemistry · doi:10.3389/fchem.2019.00665 · Cited by 20
Gabriel, J., Höfner, G., & Wanner, K. T. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112598 · Cited by 3
Metadata
- Authors
- Annis, D. A., Nickbarg, E., Yang, X., Ziebell, M. R., & Whitehurst, C. E.
- Venue
- Current Opinion in Chemical Biology
- Publisher
- Elsevier BV
- Published
- 2007-10
- Volume
- 11
- Issue
- 5
- Pages
- 518-526
- ISSN
- 1367-5931 (ISSN-L)
- OpenAlex
- W1971209239
- Cited by
- 224
- References
- 0
- FWCI
- 0.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.